Accure Therapeutics will develop a series of candidate drugs to treat central nervous system diseases. This will start with three programs on new medicines focused on therapeutic targets from Iproteos, a spin off by the University of Barcelona and the Institute for Research in Biomedicine (IRB Barcelona) and Binoure, a spin off by the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and the Spanish National Research Council (CSIC). Both Iproteos and Binoure have been integrated to Accure Therapeutics.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
